Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories


ImmunoScape takes in $14m sight
UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.
SambaNova rams through $676m series D
The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.
Daily deal net: April 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Aphea.Bio harvests more series B capital
ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.
Vizgen visualises $37m series B
Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.
HawkEye 360 hooks $55m in series C
Esri helped Allied Minds' satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.
Hack the Box cracks $10.6m round
Osage University Partners was among the investors in the cybersecurity training services provider’s series A round.
Battery Resourcers charges up with $20m
Orbia Ventures led a round for the battery production technology provider that emerged out of Worcester Polytechnic Institute.

News Continued

Snorkel AI pipes in $35m
GV returned for a series B round that increased the overall funding for Stanford’s machine learning technology developer to $50m.
Carta Healthcare carves out series A funding
CU Health Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.
Daily deal net: April 12, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Schroders shifts Carrick stake at discount
Schroder UK Public Private Trust, the rebranded fund previously led by Neil Woodford, has sold its shareholding in Carrick Therapeutics at a discount.
Paragon passes acquisition exam
University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.
Oxford Endovascular enters series A stage
University of Oxford, OSI and Parkwalk Advisors all returned for Oxford Endovascular’s $10m series A round.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg